No Data
No Data
No Data
No Data
No Data
Merck Garners Canadian Approval for Keytruda in First-line Gastroesophageal Cancer
Seeking Alpha12:03 ET
Beyond The Numbers: 4 Analysts Discuss ITT Stock
Ratings for ITT (NYSE:ITT) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The table below provides a concise overview of recent ratings by a
BenzingaApr 17 11:00 ET
ITT Inc Is Maintained at Buy by Stifel
ITT Inc Is Maintained at Buy by Stifel
Dow JonesApr 17 10:58 ET
Express News | ITT Inc : Stifel Raises Target Price to $150 From $141
Moomoo 24/7Apr 17 06:44 ET
Express News | ITT Inc : Stifel Raises Target Price to $150 From $141
Moomoo 24/7Apr 17 00:41 ET
3 Reasons Why Growth Investors Shouldn't Overlook ITT (ITT)
Yahoo FinanceApr 16 12:45 ET
No Data
No Data